Touching on risk groups, the different types of vaccines recommended for each group (first and second line), medico-legal considerations, consent and competency
Kirsty Armstrong also explored resources, vaccine hesitancy and fatigue.
The second part of the webinar focused on:
-
Summarising the burden of influenza, including beyond respiratory symptoms
-
Highlighting the JCVI recommendations for reducing the burden of influenza in high-risk populations
-
Examining the clinical and real-world evidence used to study recommended influenza vaccines
-
Outlining the role of flu vaccines in helping to protect beyond flu by preventing influenza-related hospitalisations